Tsart MCL 50 Tablet ER
By Tsart MCL
Rx
10 Tablet ER in a Strip

Composition
Cilnidipine(10mg) + Metoprolol Succinate(47.50mg) + Telmisartan(40mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
June, 2026

liver
When taking Tsart MCL 50 Tablet ER, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while using Tsart MCL 50 Tablet ER, so consulting your doctor is advised. If you have severe liver disease, it is not recommended to use Tsart MCL 50 Tablet ER. Make sure to discuss your liver condition with your healthcare provider before starting this medication.

kidney
Limited information is available regarding the use of Tsart MCL 50 Tablet ER in patients with kidney disease. It is advisable to consult with your doctor for further guidance.

alcohol
Avoid consuming alcohol while taking Tsart MCL 50 Tablet ER as it may not be safe. It is advised not to drink alcohol when on this medication.

driving
When taking Tsart MCL 50 Tablet ER, be cautious when driving, as it may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Tsart MCL 50 Tablet ER is not safe during pregnancy, with definite risk to the developing baby. It may be prescribed in life-threatening situations if benefits outweigh risks. Consult your doctor.

breastfeeding
It is better to consult your doctor before using Tsart MCL 50 Tablet ER during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹174.5
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024